rifamycin-based regimens
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rifamycin-based regimens, covering 2024-03-15 to 2024-03-15. Get the full timeline:
Most recent: Clinical Trial Update: Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease [Phase 4]